Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
ViewAttendees 1

BOAF2 - Harnessing Efficiency in Quantitative Systems Pharmacology (QSP) Modeling: Integrating Workflows, Automation, and Visualization Tools for Enhanced Cross-Functional Communication

Monday, November 11, 2024
3:15 PM – 4:45 PM MST
Location: Kaibab & Lantana

    Chair(s)

  • Alice Zong, MSPH

    Associate Director, Clinical Pharmacology and Pharmacometrics
    Johnson & Johnson, United States

    • Chair and Speaker(s)

  • Rajat Desikan, PhD (he/him/his)

    Director
    Clinical Pharmacology Modelling & Simulation – Vaccines & Infectious Diseases, Precision Medicine, GSK
    Rotherham, England, United Kingdom

    • Speaker(s)

  • Jane Bai, PhD (she/her/hers)

    Expert Regulatory Scientist (Systems Pharmacology)
    Center for Drug Evaluation and Research, US Food and Drug Administration
    Silver Spring, Maryland, United States

  • Ryan Suderman, PhD (he/him/his)

    Associate Director/Sr. Principal Scientist
    Simulations Plus, Inc.
    Westerville, Ohio, United States

    • Panelist(s)

  • TZ

    Tongli Zhang, PhD (he/him/his)

    Associate Professor Pharmacology & Systems Physiology
    College of Medicine University of Cincinnati, United States

  • Corey Bishop, PhD (he/him/his)

    Senior Principal Scientist
    Clinical Pharmacology and Pharmacometrics Johnson & Johnson, Pennsylvania, United States

Disclosure(s):
Alice Zong, MSPH: No financial relationships to disclose
Rajat Desikan, PhD: GSK: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Jane PF Bai, PhD: No financial relationships to disclose
Ryan Suderman, PhD: No financial relationships to disclose
Tongli Zhang, n/a: No financial relationships to disclose
Corey J. Bishop, PhD: Johnson & Johnson: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Presentations:

  • 3:15 PM – 3:35 PM MST
    A streamlined QSP workflow for digital-twin enabled in silico trials with chronic Hepatitis B infection

    Speaker: Rajat Desikan, PhD (he/him/his) – Clinical Pharmacology Modelling & Simulation – Vaccines & Infectious Diseases, Precision Medicine, GSK

  • 3:35 PM – 3:55 PM MST
    A streamlined communication framework needed for unleashing the power of QSP-informed drug development

    Speaker: Jane PF Bai, PhD (she/her/hers) – Center for Drug Evaluation and Research, US Food and Drug Administration

  • 3:55 PM – 4:15 PM MST
    Thales: A unified framework for clinical-scale QSP modeling

    Speaker: Ryan Suderman, PhD (he/him/his) – Simulations Plus, Inc.

  • 4:15 PM – 4:45 PM MST
    Panel Discussion

    Panelist: Rajat Desikan, PhD (he/him/his) – Clinical Pharmacology Modelling & Simulation – Vaccines & Infectious Diseases, Precision Medicine, GSK

    Panelist: Jane PF Bai, PhD (she/her/hers) – Center for Drug Evaluation and Research, US Food and Drug Administration

    Panelist: Ryan Suderman, PhD (he/him/his) – Simulations Plus, Inc.

    Panelist: Tongli Zhang, PhD (he/him/his) – College of Medicine University of Cincinnati

    Panelist: Corey J. Bishop, PhD (he/him/his) – Clinical Pharmacology and Pharmacometrics Johnson & Johnson